NO992228D0 - 1-(3-aminoindazol-5-yl)-3-fenylmetyl-syklisk urea egnet som HIV protease inhibitor - Google Patents

1-(3-aminoindazol-5-yl)-3-fenylmetyl-syklisk urea egnet som HIV protease inhibitor

Info

Publication number
NO992228D0
NO992228D0 NO992228A NO992228A NO992228D0 NO 992228 D0 NO992228 D0 NO 992228D0 NO 992228 A NO992228 A NO 992228A NO 992228 A NO992228 A NO 992228A NO 992228 D0 NO992228 D0 NO 992228D0
Authority
NO
Norway
Prior art keywords
hiv protease
phenylmethylcyclic
aminoindazol
protease inhibitor
urea suitable
Prior art date
Application number
NO992228A
Other languages
English (en)
Other versions
NO992228L (no
Inventor
James David Rodgers
Robert Frank Kaltenbach
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of NO992228D0 publication Critical patent/NO992228D0/no
Publication of NO992228L publication Critical patent/NO992228L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
NO992228A 1996-11-08 1999-05-07 1-(3-aminoindazol-5-yl)-3-fenylmetyl-syklisk urea egnet som HIV protease inhibitor NO992228L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2974596P 1996-11-08 1996-11-08
US74710496A 1996-11-08 1996-11-08
PCT/US1997/020035 WO1998020008A1 (en) 1996-11-08 1997-11-04 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors

Publications (2)

Publication Number Publication Date
NO992228D0 true NO992228D0 (no) 1999-05-07
NO992228L NO992228L (no) 1999-06-07

Family

ID=26705293

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992228A NO992228L (no) 1996-11-08 1999-05-07 1-(3-aminoindazol-5-yl)-3-fenylmetyl-syklisk urea egnet som HIV protease inhibitor

Country Status (21)

Country Link
EP (1) EP0937067B1 (no)
JP (1) JP2001503428A (no)
KR (1) KR20000053122A (no)
CN (1) CN1235602A (no)
AT (1) ATE244714T1 (no)
AU (1) AU5165198A (no)
BR (1) BR9712910A (no)
CA (1) CA2270966A1 (no)
CZ (1) CZ157599A3 (no)
DE (1) DE69723456T2 (no)
EA (1) EA199900452A1 (no)
EE (1) EE9900188A (no)
ES (1) ES2202645T3 (no)
HU (1) HUP9904676A2 (no)
IL (1) IL129727A0 (no)
LV (1) LV12375B (no)
NO (1) NO992228L (no)
PL (1) PL333421A1 (no)
SI (1) SI20074A (no)
SK (1) SK59699A3 (no)
WO (1) WO1998020008A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6870098A (en) * 1997-03-31 1998-10-22 Du Pont Merck Pharmaceutical Company, The Indazoles of cyclic ureas useful as hiv protease inhibitors
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
JP5131990B2 (ja) 2006-01-31 2013-01-30 アレイ バイオファーマ、インコーポレイテッド キナーゼ阻害剤およびその使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas

Also Published As

Publication number Publication date
LV12375B (en) 2000-04-20
KR20000053122A (ko) 2000-08-25
JP2001503428A (ja) 2001-03-13
SI20074A (sl) 2000-04-30
EA199900452A1 (ru) 2000-02-28
PL333421A1 (en) 1999-12-06
IL129727A0 (en) 2000-02-29
CN1235602A (zh) 1999-11-17
SK59699A3 (en) 1999-12-10
DE69723456T2 (de) 2004-05-27
LV12375A (lv) 1999-11-20
EP0937067B1 (en) 2003-07-09
HUP9904676A2 (hu) 2000-06-28
CA2270966A1 (en) 1998-05-14
WO1998020008A1 (en) 1998-05-14
AU5165198A (en) 1998-05-29
DE69723456D1 (de) 2003-08-14
EE9900188A (et) 1999-12-15
NO992228L (no) 1999-06-07
ES2202645T3 (es) 2004-04-01
BR9712910A (pt) 2000-03-21
ATE244714T1 (de) 2003-07-15
CZ157599A3 (cs) 1999-11-17
EP0937067A1 (en) 1999-08-25

Similar Documents

Publication Publication Date Title
WO1998045276A3 (en) 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
DK0816376T3 (da) Thrombininhibitorer som antikoagulante midler
BG100455A (en) Hiv protease inhibitors
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
DK0810209T3 (da) Alpha - and beta-aminosyre-hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
BR9908280A (pt) Inibidores de enzimas de fosfolipase
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
ATE423562T1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
BR9916004A (pt) Inibidores de proteinase c de pró-colágeno
DK0763017T3 (da) N-(3-amino-2-hydroxybutyl)sulfonamidderivater som HIV-proteaseinhibitorer
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
ES2171945T3 (es) Derivados aromaticos de amidina que sirven de inhibidores selectivos de la trombina.
ATE253359T1 (de) Antithrombotische mittel
EA200400690A1 (ru) Нуклеозиды, их препараты и их применение в качестве ингибиторов вирусных рнк-полимераз
YU62504A (sh) Triciklična 2-pirimidonska jedinjenja korisna kao inhibitori hiv reverzne transkriptoze
TR200003065T2 (tr) Nöraminidazların inhibitörleri olarak pirolidinler.
NO983511D0 (no) Difenylstilbener som pro-legemidler for COX-2-inhibitorer
NO992228D0 (no) 1-(3-aminoindazol-5-yl)-3-fenylmetyl-syklisk urea egnet som HIV protease inhibitor
LT2003003A (en) Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
SE9904128D0 (sv) Novel compounds
ATE286395T1 (de) Antithrombotische mittel
TR200102033T2 (tr) HIV proteaz inhibitörleri olarak bis-amino asit sülfonamitler.
DK0666841T3 (da) Succinoylamino-hydroxyethylaminosulfaminsyrederivater til anvendelse som inhibitorer af retrovirale proteaser
WO2002010124A3 (en) Salt forms of an hiv protease inhibitor
LV12374A (lv) (4R,5S,6S,7R)-Heksahidro-1-(5-(3-aminoindazol)metil)-3-butil-5,6-dioksi-4,7-bis(fenilmetil)-2H-1,3-diazepin-2-ons si savienojuma iegusana un ka HIV proteazes inhibitora pielietojums

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application